Humanigen announces positive interim Phase 3 Data of Lenzilumab in Covid patients
Humanigen Inc has announced positive interim Phase 3 data of lenzilumab in patients hospitalized with Covid-19.
Humanigen is a clinical stage biopharmaceutical company focused on...
Shocking info: Dangers of deterenol revealed
Shocking it may sound, but researchers have urged consumers to avoid using weight loss or sports supplements that list deterenol as an ingredient.
Scientists at...
Oramed Pharmaceuticals Inc starts Phase 3 Trial of Oral Insulin
Oramed Pharmaceuticals Inc announced that it has screened the first patients in its global Phase 3 trials of its oral insulin capsule ORMD-0801 for...
Freudenberg Medical showcases its silicone tubing, assemblies at CPhi & PMEC India 2021
Freudenberg Medical, a global contract manufacturer of medical device components and biopharma tubing, has showcased its premium silicone tubing, hose, and assemblies at India’s...
Bharat Biotech’s Odisha facility to make 10 types of vaccines including for Covid-19, Malaria
Bharat Biotech International Ltd (BBIL), a Hyderabad based pharma major, has said it would manufacture 10 types of vaccines. These would be produced in...
OncoSec announces first subjects dosed in Phase 1 trial of COVID-19 vaccine candidate
OncoSec Medical Inc has announced that it has dosed several subjects in its Phase 1 clinical trial of CORVax12.
According to the company, it is...
Lilly’s Bamlanivimab to be used as Covid-19 treatment
Bamlanivimab (LY-CoV555), a neutralising antibody emerged from collaboration between Lilly and Vancouver-based AbCellera, has been given authorisation by Health Canada, under the Interim Order...
NIH & BARDA react to emergency use authorisation of Moderna Covid-19 vaccine by FDA
NIH and BARDA have reacted to the United States Food and Drug Administration's Emergency Use Authorization (EUA) to Moderna, Inc., a biotechnology company based...
Women’s reproductive healthcare gets boost with home blood-testing kit for fertility
Women's fertility issues received a boost, as health start-up Yesmom announced the launch of Asia's first at-home blood testing kits for female fertility, designed...
Biocon Biologics gets $150 mn capital dose from Goldman Sachs
The Board of Biocon Biologics Ltd has approved a Rs 1,125 Crore (~USD 150 million) capital injection from Goldman Sachs.
Biocon Biologics is a subsidiary...
